NCT07881965: A Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
- State
- Under way
- Phase
- Phase 3
- People
- 300 planned
- Started
- 25 Sep 2026
- Primary completion
- 20 Feb 2029
- Arms
- WS016
- Results
- None posted
- 25 Sep 2026: Trial started
- 20 Oct 2026: Trial registered